Autoimmune disease and C-Section: new study targets bleeding risks

NCT ID NCT06730919

Completed Knowledge-focused Sponsor: RenJi Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 1,000 women with autoimmune diseases (like lupus) who had a C-section. Researchers wanted to find out how many had severe bleeding (postpartum hemorrhage) and what factors increased that risk. By analyzing medical records, they hope to identify high-risk patients and improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which women with autoimmune diseases are at highest risk for severe bleeding after C-section, leading to better prevention.
What could go wrong: This is a retrospective study, meaning it looks back at past records. It cannot prove cause and effect, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

antiphospholipid syndrome autoimmune disease Postpartum Hemorrhage rheumatoid arthritis Sjogren syndrome systemic lupus erythematosus systemic sclerosis undifferentiated connective tissue syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTPARTUM HEMORRHAGE SYSTEMIC AUTOIMMUNE DISEASES

Contacts and locations

Locations

Obstetrics & Gynecology Hospital of Fudan University

Shanghai, China
Renji Hospital, Shanghai Jiaotong University, School of Medcine

Shanghai, Shanghai Municipality, China
Shanghai First Maternity and Infant Hospital

Shanghai, China
The First Affiliated Hospital, Sun Yat-sen University

Guangzhou, China
Women's hospital school of medicine zhejiang university

Hangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.